You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
智飛生物(300122.SZ)2021年度預盈99.04億-105.64億元 同比增長200%-220%
格隆匯 01-24 18:18

格隆匯1月24日丨智飛生物(300122.SZ)公佈,預計2021年度歸屬於上市公司股東的淨利潤99.04億元-105.64億元,同比增長200%-220%;扣除非經常性損益後的淨利潤99.69億元-106.33億元,同比增長200%-220%。

公司始終重視研發創新,滿足不斷變化的疾病預防控制需求,同時將領先的研發技術與高效的市場推廣有機結合,形成了以市場需求為導向、以研發創新促發展的良性循環,推動了公司長期、穩健、可持續發展。報吿期內,公司緊緊圍繞經營發展目標持續發力,加大研發投入推陳出新,自主產品和代理產品銷售均持續穩步提升,公司主營業務收入、淨利潤等重要財務指標較上年同期將有較大幅度增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account